These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25163724)

  • 1. GH signaling in skeletal muscle and adipose tissue in healthy human subjects: impact of gender and age.
    Vestergaard PF; Vendelbo MH; Pedersen SB; Juul A; Ringgard S; Møller N; Jessen N; Jørgensen JO
    Eur J Endocrinol; 2014 Nov; 171(5):623-31. PubMed ID: 25163724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment.
    Clasen BF; Poulsen MM; Escande C; Pedersen SB; Møller N; Chini EN; Jessen N; Jørgensen JO
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2565-73. PubMed ID: 25050904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH signaling in human adipose and muscle tissue during 'feast and famine': amplification of exercise stimulation following fasting compared to glucose administration.
    Vendelbo MH; Christensen B; Grønbæk SB; Høgild M; Madsen M; Pedersen SB; Jørgensen JO; Jessen N; Møller N
    Eur J Endocrinol; 2015 Sep; 173(3):283-90. PubMed ID: 26034073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.
    Nielsen C; Gormsen LC; Jessen N; Pedersen SB; Møller N; Lund S; Jørgensen JO
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2842-50. PubMed ID: 18460563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone signaling and action in obese versus lean human subjects.
    Høgild ML; Bak AM; Pedersen SB; Rungby J; Frystyk J; Møller N; Jessen N; Jørgensen JOL
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E333-E344. PubMed ID: 30576246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus.
    Jørgensen JO; Jessen N; Pedersen SB; Vestergaard E; Gormsen L; Lund SA; Billestrup N
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E899-905. PubMed ID: 16757551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment.
    Dal J; Høyer KL; Pedersen SB; Magnusson NE; Bjerring P; Frystyk J; Møller N; Jessen N; Jørgensen JO
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3716-3723. PubMed ID: 27466699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of fasting on growth hormone signaling and action in muscle and fat.
    Moller L; Dalman L; Norrelund H; Billestrup N; Frystyk J; Moller N; Jorgensen JO
    J Clin Endocrinol Metab; 2009 Mar; 94(3):965-72. PubMed ID: 19066303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.
    Jessen N; Djurhuus CB; Jørgensen JO; Jensen LS; Møller N; Lund S; Schmitz O
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E194-9. PubMed ID: 15339744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.
    Vahl N; Møller N; Lauritzen T; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3612-8. PubMed ID: 9360515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment.
    Fisker S; Kristensen K; Rosenfalck AM; Pedersen SB; Ebdrup L; Richelsen B; Hilsted J; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2001 Feb; 86(2):792-6. PubMed ID: 11158048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men.
    Krusenstjerna-Hafstrøm T; Vestergaard ET; Buhl M; Nielsen R; Clasen BF; Nielsen S; Møller N; Pedersen SB; Jørgensen JO
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2581-9. PubMed ID: 21632809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone on adipose tissue and skeletal muscle lipoprotein lipase activity in humans.
    Richelsen B
    J Endocrinol Invest; 1999; 22(5 Suppl):10-5. PubMed ID: 10442564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults.
    Krusenstjerna-Hafstrøm T; Clasen BF; Møller N; Jessen N; Pedersen SB; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2548-57. PubMed ID: 21613350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor antagonism uncovers gender-dimorphic suppression of whole body fat oxidation in humans: differential effects of tamoxifen on the GH and gonadal axes.
    Birzniece V; Ho KK
    Eur J Endocrinol; 2015 Oct; 173(4):479-87. PubMed ID: 26199431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients.
    Doessing S; Holm L; Heinemeier KM; Feldt-Rasmussen U; Schjerling P; Qvortrup K; Larsen JO; Nielsen RH; Flyvbjerg A; Kjaer M
    Eur J Endocrinol; 2010 Dec; 163(6):853-62. PubMed ID: 20858702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors.
    Clasey JL; Weltman A; Patrie J; Weltman JY; Pezzoli S; Bouchard C; Thorner MO; Hartman ML
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3845-52. PubMed ID: 11502822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.